Condition: Opioid Use Disorder · Sponsor: Prescient Medicine Holdings, Inc.
A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population
This description comes directly from the study's public registry record.
Amanda Smith, MD · 800-800-5525 · amanda.smith@concentricsresearch.com
Always discuss trial participation with your own doctor first.
| Concentrics Research | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07135323